ProfileGDS4132 / 231620_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 19% 27% 22% 22% 25% 21% 19% 22% 20% 19% 22% 19% 22% 23% 23% 22% 21% 17% 16% 21% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10141.448819
GSM201543Muscle PCOS pioglitazone 12158.123127
GSM201544Muscle PCOS pioglitazone 16151.651522
GSM201545Muscle PCOS pioglitazone 20156.751622
GSM201829Muscle PCOS pioglitazone 23162.18325
GSM201830Muscle PCOS pioglitazon 25147.3421
GSM201831Muscle PCOS pioglitazone 27136.881119
GSM201832Muscle PCOS pioglitazone 3151.496422
GSM201833Muscle PCOS pioglitazone 4140.670320
GSM201834Muscle PCOS pioglitazone 8137.147819
GSM201835Muscle PCOS after pioglitazone 10239.209822
GSM201836Muscle PCOS after pioglitazone 12234.805519
GSM201837Muscle PCOS after pioglitazone 16238.598922
GSM201838Muscle PCOS after pioglitazone 20246.431123
GSM201839Muscle PCOS after pioglitazone 23246.598423
GSM201840Muscle PCOS after pioglitazone 25248.815722
GSM201841Muscle PCOS after pioglitazone 27235.265621
GSM201842Muscle PCOS after pioglitazone 3227.029617
GSM201843Muscle PCOS after pioglitazone 4234.55416
GSM201844Muscle PCOS after pioglitazone 8244.004121